Services

Integrated RNA and LNP Services, Built for Innovation

End-to-end capabilities supporting RNA design, delivery, characterization, and early development
Crystal NAX provides an integrated portfolio of services supporting RNA-based research and early-phase development. Our offerings span nucleic acid synthesis, RNA production, lipid nanoparticle formulation, advanced analytical characterization, and early-phase manufacturing, enabling seamless progression from concept to IND-enabling readiness. Built on a science-first, technology-driven platform, our services are designed for speed, flexibility, and quality, without the rigidity of traditional GMP manufacturing. We partner closely with our clients to deliver customized solutions aligned with project goals, timelines, and technical complexity.

Flexible DNA templates for modern RNA workflows

We provide both cell-free linear DNA (LDNA) solutions for rapid, clean, and high-throughput RNA prototyping, and traditional plasmid DNA (pDNA) preparation for established workflows. Our DNA services support efficient RNA synthesis and screening across diverse applications.

High-performance RNA for expression and genome engineering

Crystal NAX delivers mRNA, self-amplifying RNA (saRNA), circular RNA (circRNA) and high-fidelity sgRNA synthesis tailored for research and preclinical use. Our workflows emphasize speed, flexibility, and impurity control to support therapeutic development, gene editing, and immunization programs.

Programmable delivery systems for RNA applications

Our LNP services cover standard LNP synthesis, targeted LNP (tLNP) development, high-throughput formulation screening, and process development studies. These capabilities enable rapid optimization of RNA delivery systems across multiple applications and routes of administration.

Data-driven insight across RNA and nanoparticle systems

We offer comprehensive analytical services ranging from routine testing to extended characterization, method development and validation, and stability studies. Orthogonal analytical approaches ensure deep understanding of critical quality attributes and support confident R&D decisions.

GMP-like quality for advanced preclinical development

Crystal NAX provides fast timeline early-phase manufacturing applying GMP-like processes and controls without full cGMP constraints. This service bridges R&D and clinical development, supporting preclinical, toxicology, and IND-enabling programs with speed and flexibility.